Determinants of relapse periodicity in Plasmodium vivax malaria

Malaria Journal

Volumn 10, Issue , 2011, Pages

  White, Nicholas J ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

8 AMINOQUINOLONE; AMODIAQUINE PLUS ARTESUNATE; ANTIMALARIAL AGENT; ARTEMETHER PLUS BENFLUMETOL; ARTEMISININ DERIVATIVE; ARTESUNATE; ARTESUNATE PLUS MEFLOQUINE; CHLOROQUINE; DIHYDROARTEMISININ PLUS PIPERAQUINE; HALOFANTRINE; MALARIA VACCINE; MEFLOQUINE; MEPACRINE; PAMAQUINE; PENTAQUINE; PLASMOQUINE; PRIMAQUINE; PROGUANIL; PYRIMETHAMINE; QUININE; QUINOLONE DERIVATIVE; SULFONAMIDE; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ADD ON THERAPY; AGE; ANOPHELES; ANTIMALARIAL DRUG RESISTANCE; APICOMPLEXAN LIFE CYCLE STAGE; BRADYZOITE; CHEMOPROPHYLAXIS; CONCENTRATION RESPONSE; CYTOKINE RESPONSE; DISEASE ASSOCIATION; DISEASE TRANSMISSION; DRUG EFFICACY; DRUG ELIMINATION; DRUG HALF LIFE; DRUG POTENTIATION; DRUG RESPONSE; DRUG TOLERABILITY; ENDEMIC DISEASE; ENVIRONMENTAL TEMPERATURE; ERYTHROCYTE; FEVER; GENETIC VARIABILITY; GEOGRAPHIC DISTRIBUTION; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; HEMOLYSIS; HISTORY OF MEDICINE; HUMAN; HYPNOZOITE; INCUBATION TIME; INSECT BITE; MALARIA FALCIPARUM; MEROZOITE; MONOTHERAPY; NEUROSYPHILIS; NONHUMAN; PERIODICITY; PHENOTYPE; PLASMODIUM OVALE; PLASMODIUM VIVAX; PLASMODIUM VIVAX MALARIA; RECRUDESCENCE; RECURRENT DISEASE; REINFECTION; RELAPSE; RELAPSE PERIODICITY; REVIEW; SCHIZONT; SPOROZOITE; SYSTEMIC DISEASE; BIOLOGICAL MODEL; GROWTH, DEVELOPMENT AND AGING; LIVER; PARASITOLOGY; PATHOGENICITY; PATHOLOGY; TIME;

HUMANS; LIVER; MALARIA, VIVAX; MODELS, BIOLOGICAL; PERIODICITY; PLASMODIUM VIVAX; RECURRENCE; TIME FACTORS;

EID: 80053624564     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-10-297     Document Type: Review

References (165)

1. Vivax malaria: neglected and not benign. Price RN, Tjitra E, Guerra CA, Yeung S, White NJ, Anstey NM, Am J Trop Med Hyg 2007 77 Suppl 6 79 87 18165478
2. The effects of Plasmodium vivax malaria in pregnancy. Nosten F, McGready R, Simpson JA, Thwai KL, Balkan S, Cho T, Hkirijaroen L, Looareesuwan S, White NJ, Lancet 1999 354 546 549 10.1016/S0140-6736(98)09247-2 10470698 (Pubitemid 29381368)
3. Nouveau parasite du sang. Laveran A, Bull Acad Natl Med 1980 9 1235 1236
4. Sulle febbri malariche estivo-autumnali di Roma. Golgi C, Gazz Med Pavia 1983 2 481 559
5. Parasites malariques chez les oiseaux. Grassi B, Feletti R, Arch Ital Biol 1890 13 297 300
6. Osservatione sul ciclo schizogonico del Plasmodium vivax. Corradetti A, Riv Malari 1936 15 3 11
7. Mededeelingen uit de Geneeskundige kliniek. Pel PK, Malaria infectie Ned Tijdschr Geneeskd 1886 22 341 358
8. Lectures on the malarial fevers. Thayer WS, Appleton, New York 1897 326
9. Como si prendono la febbri malariche. Recerche speriment. Bignami A, Bull R Acad (Roma) 1898 2 1786 1788
10. Experimental proof of the mosquito-malaria theory. Manson P, Br Med J 1900 2 949 951 10.1136/bmj.2.2074.949 20759182
11. Experimental malaria: recurrence after nine months. Manson PT, Br Med J 1901 2 77 10.1136/bmj.2.2115.77 20759742
12. Experimental inoculation of malaria with a relapse after eight months. Fearnside CF, Indian Med Gaz 1903 38 10
13. Malaria. Celli A, Longmans, Green & Co, London 1900
14. "The prevention of malaria". Celli A, R.Ross. John Murray, London 1911
15. Hereinneringsbundel voor Prof SS Rosenstein. Korteweg PC, Leiden 1902
16. Investigations on the transmission of malaria in some villages north of Amsterdam. Swellengrebel NH, De Buck A, Schoute E, Kraan MH, Quart Bull Health Org League of Nations 1936 3 295 352
17. Malaria in the Netherlands. Swellengrebel NH, De Buck A, Scheltema & Holkema, Amsterdam 1938
18. Long-latency in Plasmodium vivax infections in a temperate zone. Winckel CWF, Doc Med Geogr Trop 1955 7 292 298 13261908
19. The seasonal periodicity of malaria and the mechanism of the epidemic wave. Gill CA, JA Churchill Ltd. London 1938
20. Malaria in Europe. An ecological study. Hackett LW, Oxford University Press, London 1937
21. Concerning the pathogenesis of relapses in malarial fevers. Bignami A, South Med J 1913 6 79 89 10.1097/00007611-191302000-00002
22. Observations on malaria made during the treatment of general paralysis. Yorke W, MacFie JWS, Trans R Soc Trop Med Hyg 1924 18 13 37 10.1016/S0035- 9203(24)90664-X
23. Further observations on malaria made during the treatment of general paralysis. Yorke W, Trans R Soc Trop Med Hyg 1925 19 108 122
24. Some general results of a study of induced malaria in England. James SP, Trans R Soc Trop Med Hyg 1931 24 477 538 10.1016/S0035-9203(31)90068-0
25. Clinical and parasitological observations on induced malaria. James SP, Nicol WD, Shute PG, Proc R Soc Med 1936 29 27 42
26. Report on the first results of laboratory work on malaria in England. James SP, Shute PG, League of Nations. Health Organisation Geneva. C. H. Malaria 1926 57 30
27. Pathology-Experimental malaria with protracted incubation. Schuffner WAC, Kortweg PC, Swellengrebel NH, Proc Roy Acad Sci Amsterdam 1929 32 903 911
28. Dates of onset of relapses and the duration of infection in induced tertian malaria with short and long incubation periods. Tiburskaja NA, Sergiev PO, Vrublevskaja OS, Bull World Health Organ 1968 38 447 457 4876427
29. Subspecies of the parasite of tertian malaria (Plasmodium vivax). Nikolaiev BP, Dokl Akad Navk USSR 1949 67 201 210
30. The Madagascar strain of Plasmodium vivax. Shute PG, Garnham PCC, Maryon M, Arch Inst Pasteur Madagascar 1978 47 173 183
31. On strains or races of the malaria parasites. Boyd MF, Am J Trop Med 1940 20 69 80
32. Studies on malaria with special reference to treatment. XV. Does the strain of parasite influence cure? Sinton JA, Indian J Med Res 1931 18 845 853
33. A controlled technique for the employment of naturally induced malaria in the therapy of paresis. Boyd MF, Stratman-Thomas WK, Am J Hyg 1933 17 37 43
34. A review of studies on immunity to vivax malaria. Boyd MF, J Natl Malar Soc 1947 6 12 31 20263110
35. Studies in human malaria. V. Homologous strain superinfection during latency in subjects with sporozoite-induced vivax malaria (St. Elizabeth strain). Cooper WC, Coatney GR, Ruhe DS, Am J Hyg 1947 46 141 148 20252855
36. Studies in human malaria. XVI. Results of massive sub-inoculation during latency from patients infected with St. Elizabeth strain vivax malaria. Cooper WC, Ruhe DS, Coatney GR, Am J Trop Med Hyg 1949 50 189 193
37. On the duration of homologous immunity to Plasmodium vivax. Boyd MF, Stratman-Thomas WK, Kitchen SF, Am J Trop Med 1936 21 1 16 311-315
38. The influence of sporozoite dosage in vivax malaria. Boyd MF, Am J Trop Med 1940 20 279 286
39. The study of a regional epidemic of malaria in Northern Sind. Covell G, Baily JD, Record Malaria Survey of India 1932 3 279 321
40. Recent advances in chemotherapy Malaria. Findlay GM, The Blakiston Company, Philadelphia 1951 Vol 2
41. Induced and war malaria. Höring RO, J Trop Med Hyg 1947 50 150 159 20258717
42. Studies on imported malarias the parasitological pattern of relapsing Plasmodium vivax in military patients. Eyles DE, Young MD, J Natl Mal Soc 1948 7 23 37
43. Malaria in China and the Equatorial Pacific Area from 1937 to 1943. Ebisawa I, Yale J Biol Med 1973 46 94 101 4611054
44. Report on relapsing vivax malaria. MRC Malaria sub-committee, 1945 MLE 30
45. Statistics of malaria. Mowrey FH, Internal Medicine in World War II Office of the Surgeon General, Department of the Army 1963 2 449 463 Infectious diseases
46. Malaria among prisoners of war in Siam (F Force). Wilson T, Reid JA, Trans R Soc Trop Med Hyg 1949 43 257 272 10.1016/0035-9203(49)90003-6 15395876
47. Clinical trials of anti-malarial drugs. Most H, Internal Medicine in World War II 1963 2 525 598 Infectious diseases. Office of the Surgeon General, Department of the Army
48. Natural course of Southwest Pacific malaria. Noe WL, Green CC, Cheney G, Am J Med Sci 1946 211 215 228 21013591
49. Long term observation of Plasmodium vivax malaria. Bianco AA, Saunders GM, Levine AS, Cohn RV, US Naval Med Bull 1947 47 550
50. The Chesson strain of Plasmodium vivax malaria; clinical aspects. Whorton CM, Yount E, Jones R, Alving AS, Pullman TN, Craige B, Eichelberge L, J Infect Dis 1947 80 237 49 10.1093/infdis/80.3.237 20247931
51. The Chesson strain of Plasmodium vivax malaria. I. Relationship between prepatent period, latent period and relapse rate. Craige B Jr, Alving AS, Jones R Jr, Whorton CM, Pullman TN, Eichelberger L, J Infect Dis 1947 80 228 236 10.1093/infdis/80.3.228 20247930
52. Relapses with Chesson strain Plasmodium vivax following treatment with chloroquine. Jeffery GM, Am J Trop Med Hyg 1956 5 1 13 13292645
53. Studien uber krankheitserregende Protozoen.II. Plasmodium vivax (Grassi & Feletti) der Erreger des Tertianfiebers beim Menschen. Schaudinn F, Arb Kais Gesundheitsamte (Berlin) 1902 19 169 250
54. New knowledge of the life cycle of malaria parasites. James SP, Tate P, Nature 1937 139 545 549 10.1038/139545a0
55. Chemotherapeutic suppression and prophylaxis in malaria. Fairley NH, Trans R Soc Trop Med Hyg 1945 38 311 365 10.1016/0035-9203(45)90038-1 20293965
56. Sidelights on malaria in man obtained by subinoculation experiments. Fairley NH, Trans R Soc Trop Med Hyg 1947 40 621 676 10.1016/0035-9203(47)90025- 4 20243883
57. Malaria with special reference to certain experimental, clinical, and chemotherapeutic investigations. Lecture 1: The life cycle. Fairley NH, Brit Med J 1949 2 825 830 10.1136/bmj.2.4632.825 18143458
58. Exoerythrocytic schizogony in Plasmodium kochi Laveran. A preliminary note. Garnham PCC, Trans R Soc Trop Med Hyg 1947 40 719 722 10.1016/0035- 9203(47)90029-1 20243887
59. Pre-erythrocytic stage in mammalian malaria parasites. Shortt HE, Garnham PCC, Nature 1948 161 126 18933854
60. Demonstration of a persisting exo-erythrocytic cycle in Plasmodium cynomolgi and its bearing on the production of relapses. Shortt HE, Garnham PCC, Brit Med J 1948 1 1225 1228 10.1136/bmj.1.4564.1225 18865981
61. The pre-erythrocytic stage of human malaria, Plasmodium vivax. Shortt HE, Garnham PCC, Covell G, Shute PG, Brit Med J 1948 1 547 18933175
62. The pre-erythrocytic stage of mammalian malaria. Shortt HE, Garnham PCC, Malamos B, Brit Med J 1948 1 192 194 10.1136/bmj.1.4543.192 18899048
63. Relapses and latency in malaria. Garnham PCC, Protozoology 1967 2 55 64
64. The pre-erythrocytic development of Plasmodium cynomolgi and Plasmodium vivax. Shortt HE, Garnham PCC, Trans R Soc Trop Med Hyg 1948 41 785 795 10.1016/S0035-9203(48)80006-4 18865442
65. Relapses in primate malaria: Discovery of two populations of exoerythrocytic stages. Preliminary note. Krotoski WA, Krotoski DM, Garnham PCC, Bray RS, Killick-Kendrick R, Draper CC, Targett OAT, Guy MW, Brit Med J 1980 1 153 154 (Pubitemid 10215118)
66. Demonstration of hypnozoites in sporozoite-transmitted Plasmodium vivax infection. Krotoski WA, Collins WE, Bray RS, Garnham PCC, Cogswell FB, Gwadz RW, Killick-Kendrick R, Wolf R, Sinden R, Koontz LC, Stanfill PS, Am J Trop Med Hyg 1982 31 1291 1293 6816080 (Pubitemid 13203888)
67. Discovery of the hypnozoite and a new theory of malarial relapse. Krotoski WA, Trans R Soc Trop Med Hyg 1985 79 1 11 10.1016/0035-9203(85)90221-4 3922096
68. Swellengrebel lecture. Hypnozoites and 'relapses' in Plasmodium vivax and in vivax-like malaria. Garnham PC, Trop Geogr Med 1988 40 187 95 3055568 (Pubitemid 19220697)
69. The life-cycle of primate malaria parasites. Bray RS, Garnham PC, Br Med Bull 1982 38 117 22 7052190 (Pubitemid 12008179)
70. Towards an in vitro model of Plasmodium hypnozoites suitable for drug discovery. Dembele L, Gego A, Zeeman AM, Franetich JF, Silvie O, Rametti A, Le Grand R, Dereuddre-Bosquet N, Sauerwein R, van Gemert GJ, Vaillant JC, Thomas AW, Snounou G, Kocken CH, Mazier D, PLoS One 2011 6 18162 10.1371/journal.pone. 0018162 21483865
71. Studies in human malaria. XVIII. The life pattern of sporozoite-induced St. Elizabeth strain vivax malaria. Coatney OR, Cooper WC, Ruhe DS, Young MD, Burgess RW, Am J Hyg 1950 51 200 215
72. Features specific to the Moscow strain of P. vivax. Tiburskaya NA, Medskayta Parazit-Moscow 1961 30 446 454
73. Explanation for the difference of incubation type and features of alteration of acute periods of tertian malaria associated with different strains of Plasmodium vivax. Moshkovsky SD, Med Parazitol 1973 42 393 400 (In Russian.)
74. Endemic malaria: an 'indoor' disease in northern Europe. Historical data analysed. Huldén L, Huldén L, Heliövaara K, Malar J 2005 4 19 10.1186/1475-2875-4-19 15847704 (Pubitemid 40923595)
75. Studies in human malaria. XXX. A summary of 204 sporozoite-induced infections with the Chesson strain of Plasmodium vivax. Coatney GR, Cooper WC, Young MD, J Natl Malar Soc 1950 9 381 396 14804098
76. Southwest Pacific vivax malaria; clinical features and observations concerning duration of clinical activity. Hill E, Amatuzio DS, Am J Trop Med Hyg 1949 29 203 14 18116849
77. Some lacunae in our knowledge of the malaria parasite. Sinton JA, Indian J Malariol 1955 9 229 45 13306281
78. Studies in malaria, with special reference to treatment. Part II. The effects of treatment on the prevention of relapse in infections with Plasmodium falciparum. Sinton J, Indian J Med Res 1932 13 579 601
79. Korean vivax malaria. I. Natural history and response to chloroquine. Hankey DD, Jones R Jr, Coatney OR, Alving AS, Coker WO, Garrison PL, Donovan WN, Am J Trop Med Hyg 1953 2 958 969 13104804
80. Pre-patent periods of a tropical strain of Plasmodium vivax after inoculations of tenfold dilutions of sporozoites. Ungureanu E, Killick-Kendrick R, Garnham PCC, Branzei P, Shute PG, Trans R Soc Trop Med Hyg 1976 70 482 483 10.1016/0035-9203(76)90133-4 320727 (Pubitemid 8034800)
81. Observations on early and late post-sporozoite tissue stages in primate malaria. IV. Pre-erythrocytic schizonts and/or hypnozoites of Chesson and North Korean strains of Plasmodium vivax in the chimpanzee. Krotoski WA, Garnham PC, Cogswell FB, Collins WE, Bray RS, Gwasz RW, Killick-Kendrick R, Wolf RH, Sinden R, Hollingdale M, Lowrie RC, Koontz LC, Stanfill PS, Am J Trop Med Hyg 1986 35 263 74 3513645 (Pubitemid 16055390)
82. Compatibility of relapse patterns of Plasmodium cynomolgi infections in Rhesus monkeys with continuous cyclical development and hypnozoite concepts of relapse. Schmidt LH, Am J Trop Med Hyg 1986 35 1077 1099 3538919 (Pubitemid 17210104)
83. Studies on the chemotherapy of the human malarias; the anti-malarial activity of pamaquine. Berliner RW, Earle DP, Taggart JV, Welch WJ, Zubrod CG, Knowlton P, Atchley JA, Shannon JA, J Clin Invest 1948 27 108 13 10.1172/JCI101947 18860188
84. A retrospective examination of reinfection of humans with Plasmodium vivax. Collins WE, Jeffery GM, Roberts JM, Am J Trop Med Hyg 2004 70 642 4 15211006 (Pubitemid 38802394)
85. Studies in malaria with special reference to treatment; plasmoquine in treatment of malaria. Sinton JA, Bird W, Indian J Med Research 1928 16 159
86. Studies in malaria, with special reference to treatment. XII. Further researches into treatment of chronic benign tertian malaria with plasmoquine and quinine. Sinton JA, Smith S, Potinger D, Indian J Med Res 1930 17 793
87. The use of plasmoquine in the prevention of malarial infections. James SP, Proc R Acad Sci Amsterdam 1931 34 1424 1425
88. Studies on the chemotherapy of the human malarias. IX. Effect of pamaquine on the blood cells of man. Earle DP, Bigelow FS, Zubrod CG, Kane CA, J Clin Invest 1948 27 121 9 10.1172/JCI101950 18860190
89. Are the experimental data of therapeutic malaria applicable to conditions obtaining in nature. Winckel CWF, Am J Trop Med Hyg 1941 789 794
90. Feeding behaviour and sporozoite ejection by infected Anopheles stephens. Ponnudurai T, Lensen AHW, van-Gemart GJA, Bolmer MG, Meuwissen JH, i. Trans R Soc Trop Med Hyg 1991 85 175 180 10.1016/0035-9203(91)90012-N
91. An estimation of the number of sporozoites ejected by a feeding mosquito. Rosenburg R, Wirtz RA, Trans R Soc Trop Med Hyg 1990 84 209 212 10.1016/0035-9203(90)90258-G 2202101 (Pubitemid 20172004)
92. Quantitation of Plasmodium falciparum sporozoites transmitted in vitro by experimentally infected Anopheles gambiae and Anopheles stephensi. Beier JC, Davis JR, Vaughan JA, Noden BH, Beier MS, Am J Trop Med Hyg 1991 44 564 70 2063960
93. Renewed clinical activity in vivax malaria. Boyd MF, Kitchen SF, Am J Trop Med Hyg 1943 23 221 234
94. Statistics of malaria. Mowrey FH, Internal Medicine in World War II 1963 2 449 463 Infectious diseases. Office of the Surgeon General, Department of the Army
95. Studies on the characterization of Plasmodium vivax strains from Central America. Contacos PG, Collins WE, Jeffery GM, Krotoski WA, Howard WA, Am J Trop Med Hyg 1972 21 707 712 4627547
96. Comparative genomics of the neglected human malaria parasite Plasmodium vivax. Carlton JM, Adams JH, Silva JC, Bidwell SL, Lorenzi H, Caler E, Crabtree J, Angiuoli SV, Merino EF, Amedeo P, Cheng Q, Coulson RM, Crabb BS, Del Portillo HA, Essien K, Feldblyum TV, Fernandez-Becerra C, Gilson PR, Gueye AH, Guo X, Kang'a S, Kooij TW, Korsinczky M, Meyer EV, Nene V, Paulsen I, White O, Ralph SA, Ren Q, Sargeant TJ, Salzberg SL, Stoeckert CJ, Sullivan SA, Yamamoto MM, Hoffman SL, Wortman JR, Gardner MJ, Galinski MR, Barnwell JW, Fraser-Liggett CM, Nature 2008 455 757 763 10.1038/nature07327 18843361
97. Plasmodium vivax polymorphism in a clinical drug trial. Adak T, Valecha N, Sharma VP, Clin Diagn Lab Immunol 2001 8 891 894 11527798 (Pubitemid 32868302)
98. Studies on the Plasmodium vivax relapse pattern in Delhi, India. Adak T, Sharma VP, Orlov VS, Am J Trop Med Hyg 1998 59 175 179 9684649 (Pubitemid 28304818)
99. Relapse pattern of Plasmodium vivax in Mumbai: a study of 283 cases of vivax malaria. Gogtay NJ, Desai S, Kadam VS, Kamtekar KD, Dalvi SS, Kshirsagar NA, J Assoc Phys India 2000 48 1085 1086
100. Malaria: patterns of relapse and resistance. Wajihullah Saifi MA, Siddiqui MI, Al-Khalifa MS, J King Saud University (Science) 2010 22 31 36 10.1016/j.jksus.2009.12.005
101. Efficacies of 5- and 14-day primaquine regimens in the prevention of relapses in Plasmodium vivax infections. Gogtay NJ, Desai S, Kamtekar KD, Kadam VS, Dalvi SS, Kshirsagar NA, Ann Trop Med Parasitol 1999 93 809 12 10.1080/00034989957790 10715673 (Pubitemid 30058079)
102. Radical treatment of vivax malaria in Madhya Pradesh, India. Singh N, Mishra AK, Sharma VP, Indian J Malariol 1990 27 55 6 2200726
103. Relapse/reinfection patterns of Plasmodium vivax infection: a four year study. Prasad RN, Virk KJ, Sharma VP, Southeast Asian J Trop Med Public Health 1991 22 499 503 1820634
104. Malaria relapses and chloroquine resistance at the BHEL industrial complex, Hardwar, India. Sinha S, Dua VK, Sharma VP, Trans R Soc Trop Med Hyg 1989 83 606 610 10.1016/0035-9203(89)90369-6 2694499 (Pubitemid 19252126)
105. Studies on Plasmodium vivax relapse pattern in Kheda district, Gujarat. Srivastava HC, Sharma SK, Bhatt RM, Sharma VP, Indian J Malariol 1996 33 173 179 9125831 (Pubitemid 126614404)
106. Treatment of vivax malaria in an endemic area on the western border of Thailand. Luxemburger C, van Vugt M, Jonathan S, McGready R, Looareesuwan S, White NJ, Nosten F, Trans R Soc Trop Med Hyg 1999 93 433 438 10.1016/S0035-9203(99)90149-9 10674098 (Pubitemid 29405879)
107. Clinical trial of oral artesunate with or without high-dose primaquine for the treatment of vivax malaria in Thailand. Silachamroon U, Krudsood S, Treeprasertsuk S, Wilairatana P, Chalearmrult K, Mint HY, Maneekan P, White NJ, Gourdeuk VR, Brittenham GM, Looareesuwan S, Am J Trop Med Hyg 2003 69 14 18 12932090
108. Prolonged incubation period of imported P. vivax malaria in London. Warwick R, Swimer GJ, Britt RP, J Roy Soc Med 1980 73 333 336 7017128 (Pubitemid 10031249)
109. The seasonal pattern of Plasmodium vivax malaria in Glasgow. Walker E, J Infect 1983 7 227 30 10.1016/S0163-4453(83)97088-3 6363564 (Pubitemid 14212593)
110. Relapsing vivax malaria cluster in Eritrean refugees, Israel. Kopel E, Schwartz E, Amitai Z, Volovik I, Euro Surveill 2010 15 19601 20619133
111. Malaria tertiana bei Kindern und Erwachsenen aus dem Epidemiegebiet der südlichen Türkei. Eichenlaub D, Reimann E, Bunjes R, Dtsch Med Wschr 1979 104 288 292 10.1055/s-0028-1103896 367741 (Pubitemid 9114319)
112. Plasmodium vivax infections in U.S. Army troops: failure of primaquine to prevent relapse in studies from Somalia. Smoak BL, DeFraites RF, Magill AJ, Kain KC, Wellde BT, Am J Trop Med Hyg 1997 56 231 234 9080885 (Pubitemid 27131685)
113. Two fixed-dose artemisinin combinations for drug-resistant falciparum and vivax malaria in Papua, Indonesia: an open-label randomised comparison. Ratcliff A, Siswantoro H, Kenangalem E, Maristela R, Wuwung RM, Laihad F, Ebsworth EP, Anstey NM, Tjitra E, Price RN, Lancet 2007 369 757 65 10.1016/S0140-6736(07)60160-3 17336652 (Pubitemid 46335820)
114. Determination of the Plasmodium vivax relapse pattern in Camopi, French Guiana. Hanf M, Stéphani A, Basurko C, Nacher M, Carme B, Malar J 2009 8 278 10.1186/1475-2875-8-278 19961585
115. Unexpectedly long incubation period of Plasmodium vivax malaria, in the absence of chemoprophylaxis, in patients diagnosed outside the transmission area in Brazil. Brasil P, de Pina Costa A, Saraiva Pedro R, da Silveira Bressan C, da Silva S, Tauil PL, Daniel-Ribeiro CT, Malar J 2011 10 122 10.1186/1475-2875-10-122 21569554
116. Vivax malaria with long incubation period, detected in the Federal District: three case reports. Tauil PL, Luz FC, Oliveira AP, Deckers FA, Santos JB, Rev Soc Bras Med Trop 2010 43 213 214 10.1590/S0037-86822010000200023 20464158
117. The epidemiology of malaria in a Karen population on the western border of Thailand. Luxemburger C, Thwai KL, White NJ, Webster HK, Kyle DE, Maelankirri L, Chongsuphajaisiddhi T, Nosten F, Trans R Soc Trop Med Hyg 1996 90 105 11 10.1016/S0035-9203(96)90102-9 8761562 (Pubitemid 26141072)
118. Fourth General Report of the Malaria Commission. Bull Health Org League of Nations 1937 6 895
119. The pharmacological basis for the rational use of atabrine in the treatment of malaria. Shannon JA, Earle DP, Brodie BB, Taggart JV, Berliner RW, J Pharm Exp Ther 1944 307 330
120. Atabrine studies in the field; the relation of serum atabrine level to breakthrough of previously contracted vivax malaria. Schaffer AJ, Lewis RA, Bull Johns Hopkins Hosp 1946 78 265 281 20982232
121. The present status of anti-malarial drugs. Napier LE, N Engl J Med 1945 233 38 43 10.1056/NEJM194507122330203
122. Pentaquine (SN-13,276) a therapeutic agent effective in reducing the relapse rate in vivax malaria. Alving AS, Craige B, Jones R, Whorton CM, Pullman TN, Eichelberger L, J Clin Invest 1948 27 25 33 10.1172/JCI101957 18860176
123. Primaquine, SN 13272, a new curative agent in vivax malaria; a preliminary report. Edgcomb JH, Arnold J, Yount EH, Alving AS, Eichelberger L, Jeffery G, Eyles D, Young MD, J Natl Malar Soc 1950 9 285 292 14804087
124. Comparison of primaquine, isopentaquine, SN-3883, and pamaquine as curative agents against Chesson strain vivax malaria. Cooper WC, Myatt AV, Hernandez T, Jeffery GM, Coatney GR, Studies in human malaria. XXXI., Am J Trop Med Hyg 1953 2 949 957 13104803
125. Korean vivax malaria. V. Cure of the infection by primaquine administered during long-term latency. Coatney GR, Alving AS, Jones R Jr, Hankey DD, Robinson DH, Garrison PL, Coker WG, Donovan WN, Di Lorenzo A, Marx RL, Simmons IH, Am J Trop Med Hyg 1953 2 985 988 13104808
126. Korean vivax malaria. II. Curative treatment with pamaquine and primaquine. Robinson DH, Di Lorenzo A, Marx RL, Simmons IH, Alving AS, Hankey DD, Coatney GR, Jones R, Coker WG, Garrison PL, Donovan WN, Am J Trop Med Hyg 1953 2 970 976 13104805
127. Induced primaquine resistance in vivax malaria. Arnold J, Alving AS, Clayman CB, Trans R Soc Trop Med Hyg 1961 55 345 50 10.1016/0035-9203(61)90103-1 13684386
128. The hemolytic effect of primaquine. VII. Biochemical studies of drug-sensitive erythrocytes. Beutler E, Dern RJ, Flanagan CL, Alving AS, J Lab Clin Med 1955 45 286 295 13233657
129. Enzymatic deficiency in primaquine-sensitive erythrocytes. Alving AS, Flanagan CL, Carson PE, Ickes CE, Science 1956 124 484 485 13360274
130. Korean vivax malaria. IV.Curative effect of 15 milligrams of primaquine daily for 7 days. Di Lorenzo A, Marx RL, Alving AS, Jones R, Am J Trop Med Hyg 1953 2 983 984 13104807
131. Studies in human malaria. XV. The therapeutic action of pamaquine against St. Elizabeth strain vivax malaria. Ruhe DS, Cooper WC, Coatney GR, Josephson ES, Am J Hyg 1949 49 367 373 18121216
132. Potentiation of the curative action of primaquine in vivax malaria by quinine and chloroquine. Alving AS, Arnold J, Hockwald RS, Clayman CB, Dern RJ, Beutler E, Flanagan CL, J Lab Clin Med 1955 46 301 306 13242948
133. Regional differences in the response of Plasmodium vivax malaria to primaquine as anti-relapse therapy. Goller JL, Jolley D, Ringwald P, Biggs BA, Am J Trop Med Hyg 76 203 207 200
134. Resistance to therapies for infection by Plasmodium vivax. Baird JK, Clin Microbiol Rev 2009 22 508 534 10.1128/CMR.00008-09 19597012
135. Primaquine resistance in Plasmodium vivax. Collins WE, Jeffery GM, Am J Trop Med Hyg 1996 55 243 249 8842108 (Pubitemid 26321825)
136. High rate of Plasmodium vivax relapse following treatment of falciparum malaria in Thailand. Looareesuwan S, White NJ, Chittamas S, Bunnag D, Harinasuta T, Lancet 1987 2 1052 1055 2889965
137. Mixed-species malaria infections in humans. Mayxay M, Pukrittayakamee S, Newton PN, White NJ, Trends Parasitol 2004 20 233 240 10.1016/j.pt.2004.03.006 15105024 (Pubitemid 38510320)
138. Plasmodium vivax recurrence following falciparum and mixed species malaria: risk factors and effect of anti-malarial kinetics. Douglas NM, Nosten F, Ashley EA, Phaiphun L, van Vugt M, Singhasivanon P, White NJ, Price RN, Clin Infect Dis 2011 52 612 620 10.1093/cid/ciq249 21292666
139. In vivo efficacy of artemether-lumefantrine against uncomplicated Plasmodium falciparum malaria in Central Ethiopia. Hwang J, Alemayehu BH, Hoos D, Melaku Z, Tekleyohannes SG, Teshi T, Birhanu SG, Demeke L, Gobena K, Kassa M, Jima D, Reithinger R, Nettey H, Green M, Malone JL, Kachur SP, Filler S, Malar J 2011 10 209 10.1186/1475-2875-10-209 21798054
140. Population studies of Plasmodium vivax. 1. The theory of polymorphism of sporozoites and epidemiological phenomena of tertian malaria. Lysenko AJ, Beljaev AE, Rybalka VM, Bull World Health Org 1977 55 541 549 338188 (Pubitemid 8237829)
141. Latency and long-term relapses in benign tertian malaria. Shute PO, Trans R Soc Trop Med Hyg 1946 40 189 200 10.1016/0035-9203(46)90056-9 20275230
142. The hypnozoite and relapse in primate malaria. Cogswell FB, Clin Microbiol Rev 1992 5 26 35 1735093
143. Activation of the hypnozoite: a part of Plasmodium vivax life cycle and survival. Hulden L, Hulden L, Malar J 2011 10 90 10.1186/1475-2875-10-90 21496287
144. Therapeutic responses to different anti-malarial drugs in vivax malaria. Pukrittayakamee S, Chantra A, Simpson JA, Vanijanonta S, Clemens R, Looareesuwan S, White NJ, Antimicrob Agents Chemother 2000 44 1680 1685 10.1128/AAC.44.6. 1680-1685.2000 10817728 (Pubitemid 30340814)
145. A comparison of two short-course primaquine regimens for the treatment and radical cure of Plasmodium vivax malaria in Thailand. Pukrittayakamee S, Imwong M, Chotivanich K, Singhasivanon P, Day NP, White NJ, Am J Trop Med Hyg 2010 82 542 547 10.4269/ajtmh.2010.09-0428 20348496
146. Relapses of Plasmodium vivax infection usually result from activation of heterologous hypnozoites. Imwong M, Snounou G, Pukrittayakamee S, Tanomsing N, Kim JR, Nandy A, Guthmann JP, Nosten F, Carlton J, Looareesuwan S, Nair S, Sudimack D, Day NP, Anderson TJ, White NJ, J Infect Dis 2007 195 927 933 10.1086/512241 17330781 (Pubitemid 46452096)
147. Relapses of Plasmodium vivax infection result from clonal hypnozoites activated at predetermined intervals. Chen N, Auliff A, Rieckmann K, Gatton M, Cheng Q, J Infect Dis 2007 195 934 941 10.1086/512242 17330782 (Pubitemid 46452097)
148. High genetic polymorphism of relapsing P. vivax isolates in northwest Colombia. Restrepo E, Imwong M, Rojas W, Carmona-Fonseca J, Maestre A, Acta Trop 2011 119 23 29 10.1016/j.actatropica.2011.03.012 21497586
149. Effectiveness of five artemisinin combination regimens with or without primaquine in uncomplicated falciparum malaria: an open-label randomised trial. Smithuis F, Kyaw MK, Phe O, Win T, Aung PP, Oo AP, Naing AL, Nyo MY, Myint NZ, Imwong M, Ashley E, Lee SJ, White NJ, Lancet Infect Dis 2010 10 673 681 10.1016/S1473-3099(10)70187-0 20832366
150. A review of mixed malaria species infections in anopheline mosquitoes. Imwong M, Nakeesathit S, Day NPJ, White NJ, Malar J 2011 10 253 10.1186/1475-2875-10-253 21880138
151. The first Plasmodium vivax relapses of life are usually genetically homologous. Imwong M, Boel ME, Pagornrat W, Pimanpanarak M, McGready R, Day NPJ, Nosten F, White NJ, J Infect Dis
152. Malaria parasites and other haemosporidiae. Garnham PCC, Blackwell Oxford 1966
153. An interim report on the treatment of malaria. Ross R, Trans R Soc Trop Med Hyg 1918 11 179 204 10.1016/S0035-9203(18)90007-6
154. Effect of altitude anoxia in provoking relapse in malaria. Howe CD, Duff FL, Science 1946 103 223 10.1126/science.103.2669.223 21012244
155. Clinical aspects of malaria. Levine HD, Internal Medicine in World War II 1963 2 479 492 Infectious diseases. Office of the Surgeon General, Department of the Army
156. Relapsing malaria. McLester JB, M Bull Mediterranean Theat 1945 111 113 Op 3
157. Randomised double-blind placebo-controlled efficacy trial of the SPf66 vaccine against falciparum malaria in children in north-western Thailand. Nosten F, Luxemburger C, Kyle DE, Ballou WR, Wittes J, Heh Wah, Chongsuphajaisiddhi T, Gordon DM, White NJ, Sadoff JC, Heppner DG, Lancet 1996 348 701 707 10.1016/S0140-6736(96)04465-0 8806288 (Pubitemid 26302304)
158. Long incubation of Plasmodium vivax multinucleatum as demonstrated in three experimental human cases. Jiang JB, Huang JC, Liang DS, Liu JX, Zhang SW, Cheng FC, Trans R Soc Trop Med Hyg 1982 76 845 847 10.1016/0035-9203(82)90122-5 6761911
159. Host-mediated regulation of superinfection in malaria. Portugal S, Carret C, Recker M, Armitage AE, Gonçalves LA, Epiphanio S, Sullivan D, Roy C, Newbold CI, Drakesmith H, Mota MM, Nat Med 2011 17 732 737 10.1038/nm.2368 21572427
160. Superinfection in malaria: Plasmodium shows its iron will. Portugal S, Drakesmith H, Mota MM, Embo J
161. Anti-malarial drug resistance. White NJ, J Clin Invest 2004 113 1084 1092 15085184
162. Hyperparasitaemia and low dosing are an important source of anti-malarial drug resistance. White NJ, Pongtavornpinyo W, Maude RJ, Saralamba S, Aguas R, Stepniewska K, Lee SJ, Dondorp AM, White LJ, Day NP, Malar J 2009 8 253 10.1186/1475-2875-8-253
163. Further observations on the duration of immunity to the homologous strain of Plasmodium vivax. Boyd MF, Matthews CB, Am J Trop Med Hyg 1939 19 63 67
164. Differential patterns of infection and disease with P. falciparum and P. vivax in young Papua New Guinean children. Lin E, Kiniboro B, Gray L, Dobbie S, Robinson L, Laumaea A, Schöpflin S, Stanisic D, Betuela I, Blood-Zikursh M, Siba P, Felger I, Schofield L, Zimmerman P, Mueller I, PLoS One 2010 5 9047 10.1371/journal.pone.0009047 20140220
165. The neglected burden of Plasmodium vivax malaria. Mendis K, Sina BJ, Marchesini P, Carter R, Am J Trop Med Hyg 2001 64 1-2 Suppl 97 106 11425182 (Pubitemid 32552576)